CD79a antibody can be used to identify most precursor B-cell acute leukemias, B-cell lymphomas, and some myelomas, and is often used to supplement the validation of CD20 antibodies, especially in mature B-cell lymphomas after treatment with rituximab.

Catalog number - RTU

LCR-0165-06

Catalog number - Conc.

LCM-0165-1.0

Antibody type

Mouse monoclonal antibody

Clone

HM47/ArMM-C3

Cellular localization

Cellular membranes

Positive control

Tonsils/lymph node

Antigen retrieving

Citrate

Certifications

Health Canada, IVD CE